Gut Microbiome

A cross-sectional study of salivary and gut microbiomes in hemodialysis patients with heart failure with preserved ejection fraction.

TL;DR

HFpEF in MHD patients may be associated with structural alterations in the oral microbiome, which appear more pronounced than those in the gut, with salivary Anaerocolumna enrichment as a candidate feature associated with the HFpEF group.

Key Findings

Salivary microbial community structure was significantly distinct and effectively distinguished MHD patients from healthy controls.

  • Alpha diversity and beta diversity analyses revealed a distinct salivary microbial structure in MHD groups versus controls (P < 0.05)
  • The study used 16S rRNA gene sequencing on salivary and fecal samples
  • Total sample size was n=88, comprising HFpEF (n=30), NHF (n=30), and CON (n=28) groups
  • The salivary microbiome differences were described as more pronounced than gut microbiome differences

Overall gut microbial community structure showed no significant separation between MHD groups and healthy controls.

  • Beta diversity analysis of gut microbiome showed no significant separation between groups
  • This contrasted with the salivary microbiome, which did show significant structural differences
  • Both salivary and fecal microbiomes were analyzed using 16S rRNA gene sequencing in the same cross-sectional cohort

Both MHD groups (HFpEF and NHF) showed depletion of salivary Veillonella compared to healthy controls.

  • Genus-level analysis identified Veillonella as depleted in the salivary microbiome of both MHD groups relative to CON
  • This depletion was shared across both MHD groups regardless of heart failure status
  • Findings were derived from 16S rRNA gene sequencing with genus-level compositional analysis

Both MHD groups showed depletion of gut Faecalibacterium compared to healthy controls.

  • Genus-level analysis identified Faecalibacterium as depleted in the gut microbiome of both HFpEF and NHF groups compared to CON
  • This depletion was shared across both MHD groups regardless of heart failure status
  • Faecalibacterium is a known butyrate-producing genus frequently reported as depleted in various disease states

LEfSe analysis identified salivary Anaerocolumna as a candidate microbial feature enriched in the HFpEF group specifically.

  • Linear discriminant analysis Effect Size (LEfSe) analysis was used to identify discriminating taxa
  • Salivary Anaerocolumna was highlighted as a 'promising candidate feature associated with the HFpEF group'
  • This feature distinguished HFpEF from both the NHF and CON groups
  • The authors described this as 'preliminary evidence' positioning the oral microbiome for further investigation in this high-risk population

The study design was cross-sectional with three groups: MHD patients with HFpEF, MHD patients without HF, and healthy controls.

  • Total n=88 participants across three groups: HFpEF (n=30), NHF (n=30), and CON (n=28)
  • Both salivary and fecal (gut) microbiomes were characterized for each participant
  • Microbial profiling was performed using 16S rRNA gene sequencing
  • Analyses included microbial community structure, composition, alpha diversity, beta diversity, and LEfSe

Have a question about this study?

Citation

Li L, Zhang Q, Zhang L, Wei R, Qin Y, Zhao J, et al.. (2026). A cross-sectional study of salivary and gut microbiomes in hemodialysis patients with heart failure with preserved ejection fraction.. Frontiers in cellular and infection microbiology. https://doi.org/10.3389/fcimb.2025.1683657